Innoviva (INVA) EBT Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 78.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.65% |
| Dec 31, 2025 | -10.20% |
| Sep 30, 2025 | -30.10% |
| Jun 30, 2025 | 52.44% |
| Mar 31, 2025 | -41.99% |
| Dec 31, 2024 | -20.34% |
| Sep 30, 2024 | -61.83% |
| Jun 30, 2024 | -31.78% |
| Mar 31, 2024 | -29.62% |
| Dec 31, 2023 | -27.50% |
| Sep 30, 2023 | 19.41% |
| Jun 30, 2023 | -63.37% |
| Mar 31, 2023 | -24.31% |
| Dec 31, 2022 | -29.01% |
| Sep 30, 2022 | 70.68% |
| Jun 30, 2022 | -28.68% |
| Mar 31, 2022 | -2.69% |
| Dec 31, 2021 | -27.71% |
| Sep 30, 2021 | 34.91% |
| Jun 30, 2021 | 33.99% |
| Mar 31, 2021 | 62.20% |
| Dec 31, 2020 | 44.14% |
| Sep 30, 2020 | 14.05% |
| Jun 30, 2020 | 48.69% |
| Mar 31, 2020 | 78.09% |
| Dec 31, 2019 | 41.44% |
| Sep 30, 2019 | 56.68% |
| Jun 30, 2019 | 63.70% |
| Mar 31, 2019 | 121.47% |
| Dec 31, 2018 | 157.16% |
| Sep 30, 2018 | 134.79% |
| Jun 30, 2018 | 109.91% |
| Mar 31, 2018 | 69.19% |
| Dec 31, 2017 | 57.45% |
| Sep 30, 2017 | 52.97% |
| Jun 30, 2017 | 56.16% |
| Mar 31, 2017 | 44.83% |
| Dec 31, 2016 | 68.59% |
| Sep 30, 2016 | 53.04% |
| Jun 30, 2016 | 117.98% |
| Mar 31, 2016 | 28.55% |
| Dec 31, 2015 | 28.04% |
| Sep 30, 2015 | 49.07% |
| Jun 30, 2015 | 40.52% |
| Mar 31, 2015 | -28.59% |
| Dec 31, 2014 | 24.50% |
| Sep 30, 2014 | 11.06% |
| Jun 30, 2014 | 7.42% |
| Mar 31, 2014 | 10.82% |
| Dec 31, 2013 | 22.95% |
| Sep 30, 2013 | 23.63% |
| Jun 30, 2013 | 58.00% |